# FDA Inspection 820205 - Cayman Chemical Company, Inc. - February 28, 2013

Source: https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/cbe32eb1-da29-4db2-8e5e-8278dd4f9a89
Source feed: FDA_Inspections

> FDA Inspection 820205 for Cayman Chemical Company, Inc. on February 28, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 820205
- Company Name: Cayman Chemical Company, Inc.
- Inspection Date: 2013-02-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1267154 - 2025-04-17](https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/50014726-fa53-47de-878c-6e8551c827ff)
- [FDA Inspection 1267154 - 2025-04-17](https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/a9a470c2-fcd1-4edd-a310-cfb4a0b10d2b)
- [FDA Inspection 1074100 - 2018-12-03](https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/3453ef33-da57-46f9-b6c1-2c6519ccd350)
- [FDA Inspection 904339 - 2014-11-19](https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/454ccea7-7e7c-45be-817a-8eb75003aef4)
- [FDA Inspection 759917 - 2011-12-22](https://www.keypedia.com/records/fda_inspections/cayman-chemical-company-inc/9e42869a-e31b-401c-ab71-472354b9a92d)

Company: https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c